How To Invest In Ocugen Inc Stock - OCGN Share Price Today & News | Stash

Invest in Ocugen Inc on Stash

Ocugen, Inc., formerly Histogenics Corporation, is a clinical stage biopharmaceutical company focused on discovering, developing, and commercializing a pipeline of therapies for eye diseases. The Company offers a diversified ophthalmology portfolio that includes gene therapies, biologics, and small molecules, targeting a range of retinal and ocular surface diseases. The Company is leveraging its modifier gene therapy platform to address genetically diverse inherited retinal disorders and dry age-related macular degeneration (AMD), based on nuclear hormone receptor genes NR2E3 (OCU400) and RORA (OCU410), respectively. The Company is also developing biologic therapies for wet-AMD, diabetic macular edema (DME), diabetic retinopathy (OCU200), and retinitis pigmentosa (OCU100).

To buy fractional shares of Ocugen Inc stock, you'll need to sign up for Stash and open a personal portfolio. Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share.

Ticker: OCGN

Ocugen Inc

$1.36

-7.48%

(1W)

Ocugen Inc Stock Performance Breakdown

Share Price
The last publicly stated price for one share of an investment, updated every approximately 20 minutes during market hours (usually business days between 9:30 a.m. and 4:00 p.m. ET).
Price: $1.36

Today's Change
This is how much an investment's price has changed over the last day of active trading.
Change: -0.73%

Year to Date Change (YTD)
This is the performance of the investment since the start of the year.
YTD Change: -1.45%

Dividend Yield
Some investments pay you profits or interest as you hold them.
Yield: 0.0

Last Dividend Paid
The dollar value per share that was paid out to shareholders.
Last Dividend: N/A

Last Dividend Pay Date
The date shareholders were paid out for the last dividend issued.
Pay Date: N/A

About OCGN

Ocugen, Inc., formerly Histogenics Corporation, is a clinical stage biopharmaceutical company focused on discovering, developing, and commercializing a pipeline of therapies for eye diseases. The Company offers a diversified ophthalmology portfolio that includes gene therapies, biologics, and small molecules, targeting a range of retinal and ocular surface diseases.

How to Buy Ocugen Inc Stock on Stash

  1. Enter the amount you'd like to invest in Ocugen Inc stock, then proceed to checkout.
  2. Set up your investment account in just a few minutes.
  3. Once you’ve finished your account, your Ocugen Inc shares will be added to your new portfolio.

Disclaimer

Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended for informational purposes only and should not be relied upon as the sole basis for making any investment decisions. This information should not be considered a recommendation or advice by Stash. Investors should make an independent assessment of the implications and determine that performance and yield are not reliable indicators of current and future results.